Safety and Effectiveness of Apixaban Versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation Stratified by Renal Function: A Retrospective Cohort Study-Reference-Cited by-同舟云学术

Safety and Effectiveness of Apixaban Versus Warfarin in Japanese Patients with Nonvalvular Atrial Fibrillation Stratified by Renal Function: A Retrospective Cohort Study

Published:2023-10-17 Issue:6 Volume:23 Page:721-733
ISSN:1175-3277
Container-title:American Journal of Cardiovascular Drugs
language:en
Short-container-title:Am J Cardiovasc Drugs

Author:

Morimoto Takeshi^ORCID,Hoshino Haruhiko^ORCID,Matsuo Yukako,Ibuki Tatsuki,Miyata Kayoko,Koretsune Yukihiro^ORCID

Funder

Bristol-Myers Squibb. K.K.

Pfizer Japan Inc.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40256-023-00611-7.pdf

Reference35 articles.

1. Lippi G, Sanchis-Gomar F, Cervellin G. Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge. Int J Stroke. 2021;16:217–21. https://doi.org/10.1177/1747493019897870.

2. Rehm M, Rothenbacher D, Iacoviello L, Costanzo S, Tunstall-Pedoe H, Fitton CA, et al.; BiomarCaRE Consortium. Chronic kidney disease and risk of atrial fibrillation and heart failure in general population-based cohorts: the BiomarCaRE project. ESC Heart Fail. 2022;9:57–65. https://doi.org/10.1002/ehf2.13699

3. O'Neal WT, Tanner RM, Efird JT, Baber U, Alonso A, Howard VJ, Howard G, Muntner P, Soliman EZ. Atrial fibrillation and incident end-stage renal disease: The REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Int J Cardiol. 2015;185:219–23. https://www.internationaljournalofcardiology.com/article/S0167-5273(15)00343-5/fulltext

4. Ding WY, Gupta D, Wong CF, Lip GYH. Pathophysiology of atrial fibrillation and chronic kidney disease. Cardiovasc Res. 2021;117:1046–59. https://doi.org/10.1093/cvr/cvaa258.

5. Ocak G, Khairoun M, Khairoun O, Bos WJW, Fu EL, Cramer MJ, et al. Chronic kidney disease and atrial fibrillation: a dangerous combination. PLoS ONE. 2022;17:e0266046. https://doi.org/10.1371/journal.pone.0266046.